Researching IBD: organoids
Inflammatory bowel disease (IBD) is a very challenging condition for [...]
The invisible toll of IBD
Maybe you have just been diagnosed with IBD, know someone [...]
Successful review meeting in Brussels
In words of our project coordinator neither the storm nor [...]
January New Deal Reads
A new model of intestinal epithelial regeneration: could patients benefit? [...]
Safety first: towards a reliable treatment
From the spark of the therapeutic idea until the placement [...]
December New Deal Reads
Single-cell kinetics of siRNA-mediated mRNA degradation. Krzysztoń et al. 2019. Nanomedicine: Nanotechnology, Biology, and [...]
An intestinal simulation for a real disease: testing IBD in vitro
If we take the whole human gastrointestinal (GI) tract and [...]
November New Deal Reads
Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus [...]
New Deal at UEG week 2019
Two weeks ago today, members of our consortium members participated [...]
Hitting the bull’s-eye: towards a targeted treatment for IBD
When designing a therapy, how the drug will reach the [...]